10 Hz and the amplitude set at equal to the MAP value at the beginning, was increased, if necessary, until the infant's chest was seen to be "bouncing". In the HFOV+VG mode, the VThf was set at 2 ml/kg initially on the basis of our clinical experience. The Amplitude limit was set at 15-20% above the average amplitude needed to achieve the target VTHf. Moreover during each 2 h observation period, the following variables were continuously display at 5-min intervals: FiO2, MAP, VThf, Carbon dioxide diffusion co efficiency (DCO2), Amplitude (DeltaPhf), from the ventilator records and heart rate, mean blood pressure, SpO2 from the standard cardiorespiratory monitor. Results The mean gestational age was 28,2 (24-32) week and the mean gestational weight was 1087 (704-1960) gr. There was no significant difference in the mean PCO2, FiO2, DeltaPhf, MAP, VTHf, DCO2, Minute ventilation (MVe), Dynamic compliance (CDyn), Resistance (R). Hypocarbia event (PCO2 <40 mmHg) occurred eleven (%36) sample during HFOV+VG period against seven sample (%23) during HFOV period but not statistical significant. Conclusion This preliminary result demonstrated that VG option, when combined with HFOV, a stable and feasible ventilation mode for neonatal patients and can achieve equivalent gas exchange After a careful analysis of the results, a set VTHf of 1,5 ml/kg seems to be successful achieving equivalent gas exchange using lover airway pressure. Background Hypothermia isgenerally thought to be a risk factor of respiratory distress syndrome (RDS) in premature infants. However, previous studies have primarilyinvestigated the association between hypothermia and death. Aim To investigate the association between body temperature and severe RDS. Methods The study population consists of all infants born before 32 weeks of gestationand admitted to the neonatal intensive care unit (NICU), Aalborg UniversityHospital, Denmark April 1997 and December 2011. Rectal temperature was measuredat admission. Severe RDS was defined as the need for surfactant treatment or death within the first 3 days of life in premature infants bornbefore 32 weeks gestation. Data are provided bynational registries and will be analysed by logistic regression while adjusting formarkers of infection, gestational age, time from delivery to admission, asphyxiaand a proxy variable for fetal growth restriction. Results Preliminary results from 593 infants show that64% (n = 381) had hypothermia (< 36. Background and aim Inhaled corticosteroids reduce lung inflammation in chronic lung disease (CLD) and may be safer than systemic dexamethasone treatment, but evidence of better efficacy is lacking. State-of-the-art aerosol delivery systems may permit enhanced alveolar steroid delivery compared with traditional metered-dose inhalers/spacers or jet nebulisers. We evaluated a new-generation electronic micropump vibrating-mesh nebuliser for topical airways delivery of budesonide in infants with severe CLD requiring nasal high-flow respiratory support. Methods We reviewed our units' clinical experience of delivering budesonide via the Vapotherm ventilation circuit to infants with established CLD using the Aeroneb Pro-X (Aerogen, Ireland) nebuliser. Results 7 babies with severe CLD received nebulised budesonide since 2013. Median (range) birth gestational age was 26.9 (23.1-27.7) weeks, birthweight 720 (490-850) g. Nebulisation commenced at age 62 (29-104) days postnatal, by which time 6 babies had accumulated 33 (10-49) days' systemic dexamethasone. Initial budesonide dosage was 0.5 mg/dose administered 2-4 times/day. Duration of nebulisation prior to discharge/back transfer was 55 (9-69) days. Nebulisation permitted successful weaning from dexamethasone within 8 (0-20) days in 6 babies and obviated the need for systemic dexamethasone in another. After starting nebulisation, no baby needed a subsequent oral dexamethasone course before discharge/back transfer. Conclusion Use of a new-generation electronic micropump nebuliser for topical airways budesonide delivery to nasal high-flow dependent infants is feasible and may avoid the need for systemic dexamethasone. The comparative safety and efficacy of this new technology for steroid delivery to ventilatory supportdependent CLD babies should now be formally examined in clinical trials. Background and aims Bronchopulmonary dysplasia (BPD) is the most common chronic disease associated with very preterm birth. BPD has a significant genetic background but the predisposing genes are insufficiently known. The aim is to find genetic factors that predispose to moderate-severe BPD using a hypothesis-free, genome-wide approach. Methods The study populations included preterm infants (gestational age <31 weeks) born during 1997-2013 in Oulu
Background Hypothermia isgenerally thought to be a risk factor of respiratory distress syndrome (RDS) in premature infants. However, previous studies have primarilyinvestigated the association between hypothermia and death. Aim To investigate the association between body temperature and severe RDS. Methods The study population consists of all infants born before 32 weeks of gestationand admitted to the neonatal intensive care unit (NICU), Aalborg UniversityHospital, Denmark April 1997 and December 2011. Rectal temperature was measuredat admission. Severe RDS was defined as the need for surfactant treatment or death within the first 3 days of life in premature infants bornbefore 32 weeks gestation. Data are provided bynational registries and will be analysed by logistic regression while adjusting formarkers of infection, gestational age, time from delivery to admission, asphyxiaand a proxy variable for fetal growth restriction. Results Preliminary results from 593 infants show that64% (n = 381) had hypothermia (< 36. Background and aim Inhaled corticosteroids reduce lung inflammation in chronic lung disease (CLD) and may be safer than systemic dexamethasone treatment, but evidence of better efficacy is lacking. State-of-the-art aerosol delivery systems may permit enhanced alveolar steroid delivery compared with traditional metered-dose inhalers/spacers or jet nebulisers. We evaluated a new-generation electronic micropump vibrating-mesh nebuliser for topical airways delivery of budesonide in infants with severe CLD requiring nasal high-flow respiratory support. Methods We reviewed our units' clinical experience of delivering budesonide via the Vapotherm ventilation circuit to infants with established CLD using the Aeroneb Pro-X (Aerogen, Ireland) nebuliser. Results 7 babies with severe CLD received nebulised budesonide since 2013. Median (range) birth gestational age was 26.9 (23.1-27.7) weeks, birthweight 720 (490-850) g. Nebulisation commenced at age 62 (29-104) days postnatal, by which time 6 babies had accumulated 33 (10-49) days' systemic dexamethasone. Initial budesonide dosage was 0.5 mg/dose administered 2Background and aims Bronchopulmonary dysplasia (BPD) is the most common chronic disease associated with very preterm birth. BPD has a significant genetic background but the predisposing genes are insufficiently known. The aim is to find genetic factors that predispose to moderate-severe BPD using a hypothesis-free, genome-wide approach. Methods The study populations included preterm infants (gestational age <31 weeks) born during 1997-2013 in Oulu University Hospital and during 2010-2013 in other Finnish University Hospitals (Helsinki, K uopio, Tampere, Turku). DNA samples were genotyped using the Illumina HumanCoreExome BeadChip consisting of approximately 550,000 single-nucleotide polymorphisms (SNPs); after quality control, 60 cases (moderate-severe BPD) and 114 controls (no or mild BPD) remained for a genome-wide association study (GWAS). In the next step, approximately 200 SNPs showing suggestive signals are genotyped in additional infants (n = 116/232) to determine which associations are replicated. Results In GWAS, we detected suggestive association signals (p < 1 -4 ) for several SNPs; many of these SNPs were located within or near genes that can be considered as plausible candidate genes for BPD (e.g. the CRP and PTPN6 genes encoding C-reactive protein and protein-tyrosine phosphatase SHP-1, respectively). Some of the SNPs showing suggestive associations in two previous GWASs of BPD showed weak associations (e.g. those within the PALM2 and CTNNA3 genes). Conclusions In genome-wide association study of BPD, we detected several suggestive associations. These initial results require verification in subsequent studies, including replication in additional populations and functional studies of the arising candidate genes.
PO-0745 CONGENITAL DIAPHRAGMATIC HERNIA IN NEONATES
-FIRST TIME ASSESSMENT OF OUTCOME AMONG PALESTINIAN BABIES Objectives To review our NICU and surgical experience of all cases of CDH that was admitted to our hospital in last 10 years. To identify the risk factors for morbidity and mortality. Setup Makassed Charitable Hospital, main tertiary hospital for Palestinian Territories (West Bank, Gaza and East Jerusalem). Material and methods Retrospective Review of all cases of CDH admitted to our NICU between January 2003 and December 2013. Data about: Antenatal diagnosis, gestational age, birth weight, Apgar score, Blood gas at delivery, time of surgery, finding at surgery, ventilation days, mortality outcome and several other items were recorded and analysed. Primary outcome was: mortality, total days of ventilation and total days of Oxygen requirement. Results Thirty three (n = 33) cases of CDH were reviewed. Twenty two cases were inborn (67%). Mortality was 10 cases (30%). Twenty three cases were discharged home alive and off oxygen therapy (70%). Better survival rate after 2009 (77% Vs 63%) this could be due to gentle ventilation strategies, better use of antenatal ultrasound for diagnosis. Lower mortality and less ventilation days were significantly associated with lower initial PaCO2 (p < 0.001) and higher PH (p < 0.001) and higher Gestational age (P 0.05). Presence of liver and/or spleen as part of hernia contents correlates negatively with the primary outcome (p < 0.05). Conclusion This is the first study that outlines the mortality and morbidity and their risk factors in Palestinian Territories with no ECMO is used demonstrating fairly good outcome with gentle ventilation strategies and antenatal diagnosis. Background and aims After c-section term newborns are at risk of respiratory problems. Whereas some newborns require respiratory support only for a short time in the delivery room (DR), others are admitted to the NICU for prolonged therapy. Our aim was to compare differences between newborns with respiratory support in DR only and those admitted to the NICU. Methods Retrospective analysis of video recorded DR-management of term newborns born between January 2012 and November 2013 via c-section. Results 368 newborns were analysed with 82 (22%) receiving respiratory support. From them, 26 (32%) were transported to NICU for further treatment, the remaining 56 (68%) were stabilised after a short period of CPAP treatment. There were no demographic differences between both groups. CPAP-administration started after a median of 3.4 (0.2-27) in NICU and 3.7 (0.03-17) minutes in DR infants. At the start of CPAP administration infants had a median heart rate of in DR newborns and SpO2 of 69 (41-100) and 80 (55-100) respectively (p = 0.01). 8 (31%) NICU and 15 (27%) DR newborns received a sustained inflation; mechanical ventilation via face-mask received 4 and 6 newborns respectively. In infants remaining in the DR respiratory support was stopped after a median of 7.6 (0.2-21) minutes, infants were transferred to the NICU after a respiratory support of 17.7 (4-29.6) minutes respectively. Discussion Except for lower SpO 2 values there are no parameters to predict the need for the length of treatment in respiratory depressed term newborns. Aim The diseases of newborns which involve oxidative stress are: respiratory distress (RDS), bronchopulmonary dysplasia, retinopathy and necrotizing enterocolitis. The aim of the study was to evaluate the oxidative stress trough the lipid peroxidation at preterm newborns with RDS. Material and methods We conducted a prospective, non -randomised study. The study group was represented by sixty preterm newborns with RDS. The control was represented by 20 healthy late preterm newborns. For all patients family's consent was obtained. The study of the oxidative stress was performed by the measurement of malonildyaldehide (MDA) by Satoh's method. For each newborn we determined the MDA on the first and third day of life. For the control was carried out one determination on the first day of life. The statistical analysis was done using the SPSS program. Results The RDS was present in mild form at 35% newborns, medium form at 42% and severe form at 23%. Seven newborns presented neonatal septicemia. Cerebral haemorrhage was present at 12 newborns of the study group. At 13 preterm the
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